News | Radiation Therapy | April 26, 2017

Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment

Market is expected to grow substantially, thanks to the shift towards diagnosis and treatment using precision medicine-based options

Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment

April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary brain tumors are expected to be diagnosed globally in 2017, with approximately 25,000 found to be malignant.1 As research into precision medicine continues, both patients and healthcare professionals are anticipating greater use of this type of healthcare model in the diagnosis and treatment of brain tumors. Healthcare facilities that are already focused on precision medicine-based treatments, such as the San Diego Gamma Knife Center (SDGKC) are quickly setting the standard by which other treatment centers will be measured.

Precision medicine is a driving factor in the expansion of the brain cancer diagnostics and therapeutics market, which is expected to grow extensively through 2025 to reach a value of up to $773.1 million.2 Due to increasing interest, the federal government has allocated $34 billion to the National Institutes of Health this year for the sole purpose of advancing precision medicine research.3 This initiative is especially important for brain tumor patients: The current survival rate for patients with malignant forms of brain tumors is only about 34 percent, and for pediatric cancer patients, brain tumors account for up to 25 percent of all deaths.4,5

Traditionally, treatment methods for many types of brain tumors have included invasive biopsies and surgeries, along with interventions such as chemotherapy or radiation. These conventional therapies may continue for months or years — patients often have several brain surgeries, and must try multiple anticancer drugs before finding a medication that effectively treats their unique condition.4 Unfortunately for many, these treatments do not stop tumors from growing, and they often cause a host of severe side effects that profoundly affects their quality of life.5,6

As precision medicine-based research continues, scientists and physicians are finding that targeted approaches to treatment offer the most effective options when dealing with many types of brain tumors. Tools like the Gamma Knife stereotactic radiosurgery system can be used to precisely target tumors in the brain. In many cases where the Gamma Knife treatment option is utilized, brain tumors are successfully treated during one minimally invasive, outpatient appointment.

Paul Crowe, managing partner of the San Diego Gamma Knife Center (SDGKC), said, “Brain tumor patients have one of the hardest roads to travel when it comes to diagnosis and treatment. We’re confident that precision medicine is the right way to approach treatment, and since newer therapies can be tailored to each individual, successful treatment may be more likely.”

At the center of a precision medicine-based treatment approach is the patient. Using this type of healthcare model, clinicians and researchers work together with the patient to develop a highly-personalized plan of care based on the individual’s unique circumstances. This focus on precision medicine represents the beginning of a new era in medical care, especially as attempts are made to better understand and effectively treat many types of cancers.7

“By taking a precision medicine-based approach to treatment, we can help ensure that patients receive the most effective, most appropriate therapies to address their unique needs. Precision therapies such as the Gamma Knife offer a tailored treatment plan that can be modified depending on the patient’s particular situation and the location of the tumor. It’s exciting to be able to offer patients this highly targeted treatment option,” said Crowe.

Since its opening, the San Diego Gamma Knife Center has treated over 4,000 patients with various brain disorders from around the world. The facility is equipped to provide cutting-edge treatment for a variety of conditions, including metastatic brain tumors, primary brain tumors, arteriovenous malformations, and functional disorders such as trigeminal neuralgia and cluster headaches.

For more information: www.sdgkc.com

References

1. Brain Cancer Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016-2026. Future Marketing Insights. http://www.futuremarketinsights.com/reports/brain-cancer-diagnostics-market
2. Brain Tumor Diagnosis and Therapeutics Market Worth $773.1 Million by 2025. Grand View Research. http://www.grandviewresearch.com/press-release/global-brain-tumor-diagno...
3. Senate Committee Passes $34B NIH Budget for Precision Medicine. HealthIT Analytics. http://healthitanalytics.com/news/senate-passes-34b-nih-budget-to-advanc...
4. Quick Brain Tumor Facts. National Brain Tumor Society. http://braintumor.org/brain-tumor-information/brain-tumor-facts
5. Precision medicine can be used to treat pediatric brain cancer: Study. UPI. http://www.upi.com/Health_News/2017/01/19/Precision-medicine-can-be-used...
6. Precision Medicine and the Brain Tumor Community. Cure Forward. https://www.cureforward.com/blog/precision-medicine/precision-medicine-a...
7. Global Precision Medicine Market – Growth, Trends and Forecasts (2016 – 2021). Mordor Intelligence. https://www.mordorintelligence.com/industry-reports/precision-medicine-m...

 

Related Content

Mevion Achieves CE Mark for S250i Proton Therapy System
News | Proton Therapy | November 21, 2017
November 21, 2017 — Mevion Medical Systems announced the Mevion S250i...
RayStation Selected for New Tennessee Proton Therapy Center
News | Treatment Planning | November 20, 2017
November 20, 2017 — Provision Healthcare has selected RayStation for external beam planning at the new Provision Care
Sponsored Content | Videos | Radiation Therapy | November 15, 2017
Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introd
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
ASTRO: CMS Report on Radiation Therapy Payment Model Charts Path to Value-Based Cancer Care
News | Radiation Therapy | November 08, 2017
The American Society for Radiation Oncology (ASTRO) called on the Centers for Medicare and Medicaid Services (CMS) to...
U.S. Recognizes Radiologic Technologists Nov. 5-11
News | Imaging | November 06, 2017
November 6, 2017 — During National Radiologic Technology Week (NRTW) every November, hospitals, healthcare centers an
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
PTCOG-NA Studies Address Cost and Coverage Issues With Proton Therapy
News | Proton Therapy | November 01, 2017
Physicians from across the country gathered in Chicago last week to discuss the most recent advances in proton therapy...
Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients
News | Proton Therapy | November 01, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Overlay Init